10-K · June 1, 2026
Universal Corporation reported consolidated sales of $2,924.5 million for fiscal year 2026, down 1% from $2,947.3 million in 2025, primarily due to a decline in the Tobacco Operations segment, which saw sales decrease…
10-Q · Filed November 4, 2026 · Our reading of the company's report
The latest report
Universal's second-quarter results weakened materially, with revenue down 18% to $621.8 million, operating income down 37% to $42.6 million, and diluted EPS down 63% to $0.50 year over year. The principal issue was a…
Universal's second-quarter results weakened materially, with revenue down 18% to $621.8 million, operating income down 37% to $42.6 million, and diluted EPS down 63% to $0.50 year over year. The principal issue was a 23% decline in tobacco volumes from a delayed oversupply cycle, while Ingredients Operations remained loss-making at $2.1 million. Management expects a second-half shipment recovery, but negative six-month operating cash flow of $213.8 million, higher seasonal leverage, and temporary covenant relief increase execution and liquidity risk.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Second-quarter revenue was $621.8 million, down 18% year over year, while diluted EPS was $0.50, down 63% from $1.36. Revenue and EPS were below consensus estimates of $630.1 million and $0.58, respectively.
Gross margin fell to 17.3% from 18.5%, a 120-basis-point decline. Operating income decreased 37% to $42.6 million, implying an operating margin of approximately 6.9% versus approximately 9.0% in the prior-year quarter.
Tobacco Operations revenue declined 19% to $534.3 million and operating income fell 33% to $43.9 million. Tobacco sales volumes decreased 23%, primarily because of the delayed tobacco market cycle.
Management said customer commitments are in line with full-year sales plans and that shipments are expected to be heavily weighted to the second half of fiscal 2027. Uncommitted tobacco inventories were $229.5 million, or approximately 19% of total tobacco inventory, at September 30, 2026.
Operating cash flow was negative $213.8 million for the six months ended September 30, 2026, $41.4 million worse than the prior year. The company invested $35.6 million in property, plant and equipment versus $21.1 million in the prior-year period.
The company entered into a new share repurchase authorization for up to $100 million through November 15, 2028. It repurchased 43,288 shares for $2.3 million during the quarter at an average price of $52.08.
Total debt was $1.196 billion and cash was $47.0 million at September 30, 2026, producing net debt of $1.154 billion. Net debt to net capitalization increased to 45% from 37% at March 31, 2026.
A global tobacco oversupply delayed purchasing, processing, and shipping; tobacco sales volumes fell 23% in the quarter. The company expects shipments to be heavily weighted to the second half, increasing execution and timing risk.
Uncommitted tobacco inventories totaled $229.5 million, or 19% of total tobacco inventory, at September 30, 2026. Although this was within management's target range, excess or delayed inventory could pressure cash generation and margins.
Ingredients Operations generated an operating loss of $2.1 million in the quarter and $2.7 million for the six-month period. Management cited persistent consumer-packaged-goods weakness, tight apple supplies, inflationary pressure, and high raw-material costs.
The company amended its bank credit agreement on October 9, 2026, temporarily raising the required leverage level through March 31, 2027. While the company was compliant at September 30, 2026, the amendment indicates reduced covenant headroom during the seasonal working-capital period.
No formal revenue or EPS guidance was provided. Management expects fiscal 2027 tobacco shipments to be heavily weighted to the second half, expects uncommitted inventories to decline from 19% of total tobacco inventory, and currently expects $60-$70 million of capital spending over the next twelve months.
Universal Corporation reported consolidated sales of $2,924.5 million for fiscal year 2026, down 1% from $2,947.3 million in 2025, primarily due to a decline in the Tobacco Operations segment, which saw sales decrease…
Universal reported consolidated revenue of $754.2 million for the quarter, up 6% versus $710.8 million a year ago, and delivered GAAP diluted EPS of $1.36 (up 32% year-over-year). Operating income was roughly…
Universal reported a strong quarter driven by Tobacco Operations: revenue rose 11% to $710.8 million and operating income increased 24% to $68.7 million versus the prior-year quarter, while GAAP diluted EPS fell to…
Universal reported a strong quarter: consolidated sales rose 14% year-over-year to $937.2 million and operating income increased 19% to $104.1 million for the three months ended December 31, 2024. Tobacco Operations…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
The free pages stop at the last full session. Trader shows every trade as it prints.